How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?

- Tiong, Ing Soo, Wall, Meaghan, Marlton, Paula, Johnston, Amanda, Enjeti, Anoop, Fong, Chun Yew, Cull, Gavin, Larsen, Stephen, Kennedy, Glen, Schwarer, Anthony, Kipp, David, Ramanathan, Sundra, Bajel, Ashish, Verner, Emma, Tiley, Campbell, Morris, E, Hahn, U, Moore, J, Taper, J, Purtill, D, Warburton, P, Stevenson, W, Murphy, N, Kalro, Akash, Tan, P, Beligaswatte, A, Mutsando, H, Hertzberg, M, Shortt, J, Szabo, F, Dunne, K, Wei, AH, Australasian Leukaemia and Lymphoma Group (ALLG),, Fleming, Shaun, Roberts, Andrew W., Thiagarajah, Nisha, Chua, Chong Chyn, Latimer, Maya, Yeung, David

Dietary intake of animal-based products and likelihood of follicular lymphoma and survival: A population-based family case-control study

- Odutola, Michael K., van Leeuwen, Marina T., Opat, Stephen S., Lindeman, Robert, Tiley, Campbell, Trotman, Judith, Verner, Emma, Harvey, Michael, Underhill, Craig R., Benke, Geza, Giles, Graham G., Vajdic, Claire M., Bassett, Julie K., Bruinsma, Fiona, Turner, Jennifer, Seymour, John F., Prince, Henry Miles, Milliken, Samuel T., Hertzberg, Mark, Roncolato, Fernando

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG

- Loo, Sun, Roberts, Andrew W., Taper, John, Cull, Gavin, Tiley, Campbell, Verner, Emma, Hahn, Uwe, Hiwase, Devendra K., Iland, Harry J., Murphy, Nick, Ramanathan, Sundra, Reynolds, John, Anstee, Natasha S., Ong, DM, Tiong, IS, Wall, M, Murray, M, Rawling, T, Leadbetter, J, Rowley, L, Latimer, M, Yuen, SLS, Ting, SB, Kennedy, Glen A., Fong, CY, Morris, KL, Bajel, A, Seymour, JF, Levis, MJ, Wei, AH, He, Simon, Schwarer, Anthony P., Enjeti, Anoop K., D'Rozario, James, Marlton, Paula, Bilmon, Ian A.

Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control study

- Odutola, Michael K., van Leeuwen, Marina T., Lindeman, Robert, Roncolato, Fernando, Verner, Emma, Harvey, Michael, Tiley, Campbell, Underhill, Craig R., Benke, Geza, Giles, Graham G., Vajdic, Claire M., Turner, Jennifer, Bruinsma, Fiona, Seymour, John F., Prince, H. Miles, Milliken, Samuel T., Hertzberg, Mark, Trotman, Judith, Opat, Stephen S.

Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in Australia

- Odutola, Michael K., van Leeuwen, Marina T., Roncolato, Fernando, Underhill, Craig R., Opat, Stephen S., Harvey, Michael, Hertzberg, Mark, Benke, Geza, Giles, Graham G., Vajdic, Claire M., Turner, Jennifer, Bruinsma, Fiona, Seymour, John F., Prince, Henry M., Milliken, Samuel T., Trotman, Judith, Verner, Emma, Tiley, Campbell

A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support persons

- Stevenson, William, Bryant, Jamie, Watson, Rochelle, Sanson-Fisher, Rob, Oldmeadow, Christopher, Henskens, Frans, Brown, Christina, Ramanathan, Sundra, Tiley, Campbell, Enjeti, Anoop, Guest, Johanna, Tzelepis, Flora, Paul, Christine, D'Este, Catherine

High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation

- Nath, Christa E., Trotman, Judith, Nivison-Smith, Ian, Zeng, Lihua, Shaw, Peter J., Tiley, Campbell, Presgrave, Peter, Joshua, Douglas, Kerridge, Ian, Kwan, Yiu Lam, Gurney, Howard, McLachlan, Andrew J., Earl, John W.

Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies.

- Lynagh, Marita C., Clinton-McHarg, Tara, Hall, Alix, Sanson-Fisher, Rob, Stevenson, William, Tiley, Campbell, Bisquera, Alessandra

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial

- Iland, Harry J., Collins, Marnie, Hugman, Amanda, Reynolds, John, Di Iulio, Juliana, Tiley, Campbell, Taylor, Kerry, Filshie, Robin, Seldon, Michael, Taper, John, Szer, Jeff, Moore, John, Bradstock, Ken, Bashford, John, Seymour, John F., Supple, Shane G., Catalano, Alberto, Hertzberg, Mark, Browett, Peter, Grigg, Andrew, Firkin, Frank, Campbell, Lynda J.

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

- Iland, Harry J., Bradstock, Ken, Reynolds, John, Di Iulio, Juliana, Tiley, Campbell, Taylor, Kerry, Filshie, Robin, Seldon, Michael, Taper, John, Szer, Jeff, Moore, John, Bashford, John, Supple, Shane G., Seymour, John F., Catalano, Alberto, Collins, Marnie, Hertzberg, Mark, Browett, Peter, Grigg, Andrew, Firkin, Frank, Hugman, Amanda

Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy

- Nath, Christa E., Shaw, Peter J., Presgrave, Peter, Tiley, Campbell, Joshua, Douglas, Earl, John, Trotman, Judith, Zeng, Lihua, Duffull, Stephen B., Hegarty, Gareth, McLachlan, Andrew J., Gurney, Howard, Kerridge, Ian, Kwan, Ylu Lam